TKNO
NASDAQ · Life Sciences Tools & Services
Alpha Teknova Inc
$9.20
-0.13 (-1.39%)
Financial Highlights (FY 2026)
Revenue
40.50M
Net Income
-17,250,920
Gross Margin
33.2%
Profit Margin
-42.6%
Rev Growth
-0.7%
D/E Ratio
0.19
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 33.2% | 33.2% | 29.7% | 29.7% |
| Operating Margin | -41.9% | -37.7% | 12.9% | 14.3% |
| Profit Margin | -42.6% | -40.5% | 8.2% | 10.1% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 40.50M | 40.80M | 45.50M | 44.98M |
| Gross Profit | 13.43M | 13.53M | 13.53M | 13.37M |
| Operating Income | -16,969,431 | -15,384,796 | 5.88M | 6.44M |
| Net Income | -17,250,920 | -15,639,999 | 3.71M | 4.53M |
| Gross Margin | 33.2% | 33.2% | 29.7% | 29.7% |
| Operating Margin | -41.9% | -37.7% | 12.9% | 14.3% |
| Profit Margin | -42.6% | -40.5% | 8.2% | 10.1% |
| Rev Growth | -0.7% | -0.7% | +8.6% | +16.4% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 39.96M | 39.96M | 10.30M | 10.23M |
| Total Equity | 209.42M | 209.42M | 71.30M | 78.98M |
| D/E Ratio | 0.19 | 0.19 | 0.14 | 0.13 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | -15,818,243 | -15,137,837 | 8.38M | 7.20M |
| Free Cash Flow | — | — | 3.81M | 2.92M |